VD
Vinayak Doraiswamy
Chief Scientific Officer

Vinayak Doraiswamy insider trades: AtriCure (ATRC) stock sales

Chief Scientific Officer, AtriCure Last trade Jul 28, 2026 17 Form 4 filings
$382K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
6
Open-market trades
since 2021
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Vinayak reports to the SEC

Open-market buys and sales

6 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 28, 2026ATRC↓ Sell$233K
Mar 12, 2026ATRC↓ Sell$149K
Aug 5, 2025ATRC↓ Sell$91K
May 28, 2025ATRC↓ Sell$84K
Sep 15, 2022ATRC↓ Sell$229K
Jul 12, 2021ATRC↓ Sell10b5-1$638K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ATRC insiders

Open-market trades in the last 12 months

About Vinayak Doraiswamy's insider trades

Vinayak Doraiswamy is Chief Scientific Officer at AtriCure (ATRC). Since Jul 12, 2021, Vinayak has reported no open-market purchases and 6 sales worth $1.4M on SEC Form 4. In the last 12 months: 2 sales ($382K).

1 sale (45% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include grants and awards (11 filings), shares withheld for taxes (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATRC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.